Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 07, 2020 07:00 ET | Source: Incysus Therapeutics, Inc.

Incysus Therapeutics to Present at the 2020 BIO CEO & Investor Conference

NEW YORK, Feb. 07, 2020 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc. (“Incysus”), a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the...
January 29, 2020 07:00 ET | Source: Incysus Therapeutics, Inc.

Incysus Therapeutics Announces Issuance of Foundational U.S. Patent Covering Use of Drug Resistant Immunotherapy (DRI) Technology for the Treatment of Cancer

NEW YORK, Jan. 29, 2020 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc. (“Incysus”), a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the...
November 26, 2019 07:00 ET | Source: Incysus Therapeutics, Inc.

Incysus Therapeutics to Participate in Evercore ISI HealthCONx Conference

NEW YORK, Nov. 26, 2019 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc. (“Incysus”), a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the...
November 07, 2019 07:00 ET | Source: Incysus Therapeutics, Inc.

Incysus Therapeutics to Present at the New York Oncology Investor Conference

NEW YORK, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc. (“Incysus”), a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the...
September 10, 2019 07:00 ET | Source: Incysus Therapeutics, Inc.

Incysus Therapeutics to Present at 5th Annual CAR-TCR Summit

NEW YORK, Sept. 10, 2019 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc. (“Incysus”), a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the...